Literature DB >> 9468743

Cessation of cocaine use during pregnancy: effects of contingency management interventions on maintaining abstinence and complying with prenatal care.

R Elk1, L Mangus, H Rhoades, R Andres, J Grabowski.   

Abstract

Previous studies have reported cessation of cocaine use in pregnant women prior to treatment entry. This study examined the relative effectiveness of adjunctive contingency management interventions in maintaining abstinence and enhancing compliance with prenatal care in this unique population. Pregnant cocaine-dependent women who had used the drug during this pregnancy but had ceased use prior to study entry (N = 12) were randomly assigned to one of two treatment groups. All patients received a multifaceted treatment including behaviorally based drug counseling and weekly prenatal visits. Patients in the experimental condition also received contingent reinforcement for cocaine abstinence and attendance at prenatal visits. There was a high rate of retention and abstinence from cocaine in both groups. However, patients in the experimental group had a higher rate of attendance at prenatal visits, and none of the patients in this group experienced adverse perinatal outcome(s), compared to 80% of patients in the control group. This finding has important implications for cost-effective treatments and prevention of illness.

Entities:  

Mesh:

Year:  1998        PMID: 9468743     DOI: 10.1016/s0306-4603(97)00020-8

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  16 in total

Review 1.  Contingency management interventions for tobacco and other substance use disorders in pregnancy.

Authors:  Dennis J Hand; Jennifer D Ellis; Meagan M Carr; Diane J Abatemarco; David M Ledgerwood
Journal:  Psychol Addict Behav       Date:  2017-06-22

2.  Interdependent group contingency management for cocaine-dependent methadone maintenance patients.

Authors:  Kimberly C Kirby; Marylouise E Kerwin; Carolyn M Carpenedo; Beth J Rosenwasser; Robert S Gardner
Journal:  J Appl Behav Anal       Date:  2008

3.  Effectiveness of Using Incentives to Improve Parolee Admission and Attendance in Community Addiction Treatment.

Authors:  Michael L Prendergast; Elizabeth A Hall; Jason Grossman; Robert Veliz; Liliana Gregorio; Umme S Warda; Kory Van Unen; Chloe Knight
Journal:  Crim Justice Behav       Date:  2015-07-10

Review 4.  Cognitive behavioral therapy for substance use disorders.

Authors:  R Kathryn McHugh; Bridget A Hearon; Michael W Otto
Journal:  Psychiatr Clin North Am       Date:  2010-09

5.  Prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokers.

Authors:  Rebecca L Emery; Melissa P Gregory; Jennifer L Grace; Michele D Levine
Journal:  Addict Behav       Date:  2015-12-15       Impact factor: 3.913

6.  The Protective Effect of Pregnancy on Risk for Drug Abuse: A Population, Co-Relative, Co-Spouse, and Within-Individual Analysis.

Authors:  Kenneth S Kendler; Henrik Ohlsson; Dace S Svikis; Kristina Sundquist; Jan Sundquist
Journal:  Am J Psychiatry       Date:  2017-06-09       Impact factor: 18.112

7.  Psychosocial Functioning Among Inmates in Prison-Based Drug Treatment: Results from Project BRITE.

Authors:  William M Burdon; Jef St De Lore; Jeff Dang; Umma S Warda; Michael L Prendergast
Journal:  J Exp Criminol       Date:  2013-03-01

8.  Increasing prenatal care and healthy behaviors in pregnant substance users.

Authors:  Frankie Kropp; Theresa Winhusen; Daniel Lewis; Diane Hague; Eugene Somoza
Journal:  J Psychoactive Drugs       Date:  2010-03

Review 9.  Treatment of cocaine abuse during pregnancy: translating research to clinical practice.

Authors:  Lynn Hull; James May; Dawn Farrell-Moore; Dace S Svikis
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

10.  Incentives for retention of pregnant substance users: a secondary analysis.

Authors:  Gregory Brigham; Theresa Winhusen; Daniel Lewis; Frankie Kropp
Journal:  J Subst Abuse Treat       Date:  2009-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.